Allurion Technologies (ALUR) announced that it is relaunching the Allurion Balloon in France after ANSM, the French regulatory authority, cleared Allurion to resume sales. “We are thrilled the Allurion Balloon will once again serve French patients as a clinically proven treatment for obesity,” said Shantanu Gaur, founder and CEO of Allurion. “Historically, France has been our top performing market representing approximately 15% of our revenue, and we are looking forward to ramping back up in the coming quarters.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALUR:
- Allurion Technologies Inc trading resumes
- Allurion Technologies Inc trading halted, volatility trading pause
- Allurion Technologies to sell 1.24M shares at $6 in registered direct offering
- Allurion Stock Skyrockets on Weight-Loss Study Buzz
- Allurion Technologies to initiate GLP-1 study optimizing for muscle mass
Questions or Comments about the article? Write to editor@tipranks.com